Resurgence of Polymyxin B for MDR/XDR Gram-Negative Infections: An Overview of Current Evidence

Critical Care Research and Practice- Egypt

doi 10.1155/2017/3635609

Full Text

Abstract

Available in

Categories

Intensive Care Medicine

Date

January 1, 2017

Authors

Suneel Kumar Garg

Amandeep Singh Khurana

Salman Motlekar

Hanmant Barkate

Publisher

Hindawi Limited

Related search

Antibacterial Synergism of Polymyxin B Nonapeptide and Hydrophobic Antibiotics in Experimental Gram-Negative Infections in Mice.

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

The Effect of Varying Multidrug-Resistence (MDR) Definitions on Rates of MDR Gram-Negative Rods

Antimicrobial Resistance and Infection Control

Infectious Diseases

Occupational Health

English

Polymyxin Derivatives That Sensitize Gram-Negative Bacteria to Other Antibiotics

Organic Chemistry

Molecular Medicine

Analytical Chemistry

Theoretical Chemistry

Pharmaceutical Science

English

The Effect of the Current Chemotherapy of MDR/XDR Tuberculosis on QT Interval Changes in ECG

Tuberkulëz i bolezni lëgkikh

Infectious Diseases

Respiratory Medicine

English

Ireland’s Potential MDR-TB and XDR-TB Problem

Irish Journal of Medical Science

English

Evaluation of Early Clinical Failure Criteria for Gram-Negative Bloodstream Infections

Clinical Microbiology and Infection

Infectious Diseases

English

Host Parasite Relationships in Gram-Negative Infections

Chemical Immunology and Allergy

English

Procalcitonin Levels in Gram-Positive, Gram-Negative, and Fungal Bloodstream Infections

Disease Markers

Clinical Biochemistry

Molecular Biology

English

The Changing Treatment Landscape for MDR/XDR-TB — Can Current Clinical Trials Revolutionise and Inform a Brave New World?

International Journal of Infectious Diseases

Infectious Diseases

English